A placebo-controlled randomized trial of D-cycloserine augmentation of cue exposure therapy for smoking cessation

References

• Brandon, T. H., Drobes, D. J., Unrod, M., Heckman, B. W., Oliver, J. A., Roetzheim, R. C., … Small, B. J. (2011). Varenicline effects on craving, cue reactivity, and smoking reward. Psychopharmacology (Berl), 218, 391–403. doi:10.1007/s00213-011-2327-z
   PubMed Web of Science ®Google Scholar
• Etter, J.-F., & Schneider, N. G. (2013). An internet survey of use, opinions and preferences for smoking cessation medications: Nicotine, varenicline, and bupropion. Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco, 15(1), 59–68. doi:10.1093/ntr/nts084
   PubMed Web of Science ®Google Scholar
• Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerstrom, K. O. (1991). The Fagerstrom test for nicotine dependence: A revision of the Fagerstrom tolerance questionnaire. British Journal of Addiction, 86, 1119–1127. doi:10.1111/j.1360-0443.1991.tb01879.x
   PubMedGoogle Scholar
• Hofmann, S. G., Huweler, R., MacKillop, J., & Kantak, K. M. (2012). Effects of D-cycloserine on craving to alcohol cues in problem drinkers: Preliminary findings. The American Journal of Drug and Alcohol Abuse, 38, 101–107. doi:10.3109/00952990.2011.600396
   PubMed Web of Science ®Google Scholar
• Kamboj, S. K., Joye, A., Das, R. K., Gibson, A. J., Morgan, C. J., & Curran, H. V. (2012). Cue exposure and response prevention with heavy smokers: A laboratory-based randomised placebo-controlled trial examining the effects of D-cycloserine on cue reactivity and attentional bias. Psychopharmacology (Berl), 221, 273–284. doi:10.1007/s00213-011-2571-2
   PubMed Web of Science ®Google Scholar
• Kamboj, S. K., Massey-Chase, R., Rodney, L., Das, R., Almahdi, B., Curran, H. V., & Morgan, C. J. A. (2011). Changes in cue reactivity and attentional bias following experimental cue exposure and response prevention: A laboratory study of the effects of D-cycloserine in heavy drinkers. Psychopharmacology (Berl), 217, 25–37. doi:10.1007/s00213-011-2254-z
   PubMed Web of Science ®Google Scholar
• LaRowe, S. D., Saladin, M. E., Carpenter, M. J., & Upadhyaya, H. P. (2007). Reactivity to nicotine cues over repeated cue reactivity sessions. Addictive Behaviors, 32, 2888–2899. doi:10.1016/j.addbeh.2007.04.025
   PubMed Web of Science ®Google Scholar
• MacKillop, J., Few, L. R., Stojek, M. K., Murphy, C., Malutinok, S. F., Johnson, F. T., … Monti, P. M. (2015). D-cycloserine to enhance extinction of cue-elicited craving for alcohol: A translational approach. Translational Psychiatry, 5, e544. doi:10.1038/tp.2015.41
   PubMed Web of Science ®Google Scholar
• Myers, K. M., & Carlezon, W. A., Jr. (2012). D-cycloserine effects on extinction of conditioned responses to drug-related cues. Biological Psychiatry, 71, 947–955. doi:10.1016/j.biopsych.2012.02.030
   PubMed Web of Science ®Google Scholar
• Nic Dhonnchadha, B. A., Szalay, J. J., Achat-Mendes, C., Platt, D. M., Otto, M. W., Spealman, R. D., & Kantak, K. M. (2010). D-cycloserine deters reacquisition of cocaine self-administration by augmenting extinction learning. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, 35, 357–367. doi:10.1038/npp.2009.139
   PubMed Web of Science ®Google Scholar
• Otto, M. W., Kredlow, M. A., Smits, J. A. J., Hofmann, S. G., Tolin, D. F., de Kleine, R. A., … Pollack, M. H. (2015). Enhancement of psychosocial treatment with D-cycloserine: Models, moderators, and future directions. Biological Psychiatry, 80, 274–283. doi:10.1016/j.biopsych.2015.09.007
   PubMed Web of Science ®Google Scholar
• Otto, M. W., McHugh, R. K., & Kantak, K. M. (2007). Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders: Medication effects, clucocorticoids, and attenuated outcomes. Clinical Psychology: Sciences Practical, 17, 91–103. doi:10.1111/j.1468-2850.2010.01198.x
   Google Scholar
• Otto, M. W., Smits, J. A. J., & Reese, H. E. (2005). Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults: Review and analysis. Clinical Psychol: Sciences Practical, 12, 72–86. doi:10.1093/clipsy.bpi009
   Web of Science ®Google Scholar
• Pachas, G. N., Gilman, J., Orr, S. P., Hoeppner, B., Carlini, S. V., Loebl, T., … Evins, A. E. (2014). Single dose propranolol does not affect physiologic or emotional reactivity to smoking cues. Psychopharmacology (Berl), 232, 1619–1628. doi:10.1007/s00213-014-3797-6
   PubMed Web of Science ®Google Scholar
• Pericot-Valderde, I., Germeroth, L. J., & Tiffany, S. T. (2016). The use of virtual reality in the production of cue-specific craving for cigarettes: A meta-analysis. Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco, 18, 538–546. doi:10.1007/s00213-014-3797-6
   PubMed Web of Science ®Google Scholar
• Physicians’ Desk Reference. (2006). Montvale, NJ: Thompson PDR.
   Google Scholar
• Santa, A. E. J., Rounsaville, B. J., Frankforter, T. L., Nich, C., Babuscio, T., Poling, J., … Carroll, K. M. (2009). D-cycloserine attenuates reactivity to smoking cues in nicotine dependent smokers: A pilot investigation. Drug and Alcohol Dependence, 104, 220–227. doi:10.1016/j.drugalcdep.2009.04.023
   PubMed Web of Science ®Google Scholar
• Smits, J. A. J., Rosenfield, D., Otto, M. W., Marques, L., Davis, M. L., Meuret, A. E., … Hofmann, S. G. (2013). D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions. Journal of Psychiatric Research, 47, 1455–1461.
   PubMed Web of Science ®Google Scholar
• Smits, J. A. J., Rosenfield, D., Otto, M. W., Powers, M. B., Hofmann, S. G., Telch, M. J., … Tart, C. D. (2013). D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: Evidence from the treatment of height phobia. Biological Psychiatry, 73, 1054–1058. doi:10.1016/j.biopsych.2012.12.009
   PubMed Web of Science ®Google Scholar
• Tiffany, S. T., Cox, L. S., & Elash, C. A. (2000). Effects of transdermal nicotine patches on abstinence-induced and cue-elicited craving in cigarette smokers. Journal of Consulting and Clinical Psychology, 68, 233–240. doi:10.1037/0022-006X.68.2.233
   PubMed Web of Science ®Google Scholar
• Waters, A. J., Shiffman, S., Sayette, M. A., Paty, J. A., Gwaltney, C. J., & Balabanis, M. H. (2004). Cue-provoked craving and nicotine replacement therapy in smoking cessation. Journal of Consulting and Clinical Psychology, 72, 1136–1143. doi:10.1037/0022-006X.72.6.1136
   PubMed Web of Science ®Google Scholar
• Watson, B. J., Wilson, S., Griffin, L., Kalk, N. J., Taylor, L. G., Munafo, M. R., … Nutt, D. J. (2011). A pilot study of the effectiveness of D-cycloserine during cue-exposure therapy in abstinent alcohol-dependent subjects. Psychopharmacology (Berl), 216, 121–129. doi:10.1007/s00213-011-2199-2
   PubMed Web of Science ®Google Scholar
• Welsch, S. K., Smith, S. S., Wetter, D. W., Jorenby, D. E., Fiore, M. C., & Baker, T. B. (1999). Development and validation of the Wisconsin Smoking Withdrawal Scale. Experiments Clinical Psychopharmacology, 7, 354–361. doi:10.1037/1064-1297.7.4.354
   PubMed Web of Science ®Google Scholar
• Yoon, J. H., Newton, T. F., Haile, C. N., Bordnick, P. S., Fintzy, R. E., Culbertson, C., et al. (2013). Effects of D-cycloserine on cue-induced craving and cigarette smoking among concurrent cocaine- and nicotine-dependent volunteers. Addictive Behaviors, 201338, 1518–1526. doi:10.1016/j.addbeh.2012.03.022
   Google Scholar